This podcast was recorded on July 21, 2025. Tim Beyers: Is it time to buy biotech? You're listening to Motley Fool Money.

When Eli Lilly reports its financial results before the market open Thursday, investors will be looking for the company to ...

A panel of federal appeals judge ruled that four major drug makers acted similarly enough in substance and timing by restricting pharmaceutical subsidies and raising prices of certain popular diabetes ...

Drugmakers Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca must face a lawsuit from two health centers accusing them of conspiring to restrict drug discounts offered to community pharmacies that ...

Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better ...

Novo Nordisk’s outgoing CEO, Lars Fruergaard Jorgensen, has warned that layoffs at the Danish pharmaceutical giant could be ...

The 2026 Lilly Endowment Community Scholarship application is now available in Brown County through the Brown County ...

Eli Lilly is eligible for 100M in tax credits to expand its Pleasant Prairie facility, adding 750 jobs and boosting Wisconsin ...

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

President Donald Trump said the U.S. could impose tariffs on pharmaceuticals as high as 250%, the steepest rate proposed to date, as part of a push to bring more drug manufacturing to the U.S., CNBC ...

In this week’s edition of InnovationRx, we look at a biotech entrepreneur treating a rare genetic disease, new tech aimed at ...

In a pooled analysis of three randomized trials, CPAP had overall null cardiovascular effects in patients with obstructive ...